Kangyue Technology Co Ltd - Asset Resilience Ratio
Kangyue Technology Co Ltd (300391) has an Asset Resilience Ratio of 0.01% as of December 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Kangyue Technology Co Ltd (300391) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2020)
This chart shows how Kangyue Technology Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Kangyue Technology Co Ltd total assets.
Liquid Assets Composition Over Time
This chart breaks down Kangyue Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 300391 liabilities breakdown for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥500.00K | 0.01% |
| Total Liquid Assets | CN¥500.00K | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Kangyue Technology Co Ltd maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Kangyue Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare Kangyue Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Jiuzhitang Co Ltd
SHE:000989 |
Drug Manufacturers - Specialty & Generic | 7.86% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for Kangyue Technology Co Ltd (2020–2020)
The table below shows the annual Asset Resilience Ratio data for Kangyue Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.01% | CN¥500.00K ≈ $73.17K |
CN¥4.68 Billion ≈ $685.28 Million |
-- |
About Kangyue Technology Co Ltd
Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminators and stack welding machines; and Chinese herbal medicines and hollow capsules, as well as engages in pharmaceutical distribution business. The company wa… Read more